新型口服组织蛋白酶C抑制剂BI 1291583的临床前及1期开发
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583.
作者信息
Chalmers James D, Badorrek Philipp, Diefenbach Claudia, Kögler Harald, Sauter Wiebke, Kreideweiss Stefan, Hohlfeld Jens M
机构信息
Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
Department of Clinical Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
出版信息
ERJ Open Res. 2024 Mar 25;10(2). doi: 10.1183/23120541.00725-2023. eCollection 2024 Mar.
Abstract
摘要
https://bit.ly/47PZ8E5. （此为链接，无法准确翻译出具体内容，保留原文链接形式）
Zotero 插件